Real-time enrollment status for this nash clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 2:55 AM UTC
| NCT Number | NCT06632444 |
| Recruiting Status | Recruiting |
| Condition | NASH |
| Phase | PHASE3 |
| Target Enrollment | 1,800 participants |
| Active Locations | 165 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | July 9, 2026 (1 week ago) |
As of July 19, 2026: Clinical trial NCT06632444 is currently recruiting participants. This phase3 study for nash is actively seeking new participants at 165 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06632444 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 165 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06632444 was last updated 1 week ago (July 9, 2026). HelloStudys verifies this status automatically.